Skip to content

Clinical trials

Phase 1 Fallopian Tube Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 1 Clear all

208 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20014
20024
20037
20046
20053
20063
20077
20087
20097
201010
201110
20129
20134
201411
20159
20169
201711
20188
201916
20205
20217
202212
20237
20245
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed124
Terminated30
Active, not recruiting20
Recruiting14
Withdrawn8
Unknown status7
Not yet recruiting3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)25
M.D. Anderson Cancer Center15
Gynecologic Oncology Group11
Memorial Sloan Kettering Cancer Center9
Masonic Cancer Center, University of Minnesota6
Roswell Park Cancer Institute6
Mayo Clinic5
City of Hope Medical Center4
Abramson Cancer Center at Penn Medicine3
Celldex Therapeutics3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms208
Ovarian Neoplasms157
Carcinoma, Ovarian Epithelial72
Endometrial Neoplasms40
Breast Neoplasms27
Carcinoma, Non-Small-Cell Lung22
Uterine Cervical Neoplasms22
Stomach Neoplasms19
Carcinoma, Renal Cell17
Neoplasms17

Trials

Showing 76 to 100 of 208. Each trial links to its page on Pharma Observatory.

108 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.